SEC Form 3 · accession 0001065949-15-000188
CANNAPHARMARX, INC. · CPMD
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
James E Smeeding
Director
Period of report
Jun 29, 2015
Accepted (ET)
Jul 21, 2015 · 7:24 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001081938
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | holding | — | — | — | 1,250,000 | D |
Table II — derivative securities
| Security | Conv. / exercise price | Date | Code | Shares | A/D | Exercisable | Expires | Underlying | Underlying shares | Owned after | D/I |
|---|---|---|---|---|---|---|---|---|---|---|---|
| Stock OptionsF2 | $1.00 | holding | — | — | — | Nov 1, 2015 | Nov 1, 2024 | Common Stock | 750,000 | — | D |
Explanation of responses
- F1Pursuant to the June 29, 2015 closing of the merger contemplated by the Amended and Restated Agreement and Plan of Merger dated April 21, 2015, all of the issued and outstanding capital stock of CannaPharmaRX, Inc., a Colorado corporation, was converted into shares of common stock, par value $0.0001 per share, of the Issuer. Mr. Smeeding received 1,250,000 shares pursuant to the merger.
- F2Subject to Mr. Smeeding's continued services to the Board of Directors or as an employee of CannaPharmaRx, Inc., the stock option awards will vest over three years, one-third each year.